Genprex to present at H.C. Wainwright Global Investment Conference
GNPX•Conference presentation details
Genprex will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York on Sept. 14-16.
Management presentation is scheduled for Sept. 14, 3:30-4 p.m. ET.
The presentation will cover Reqorsa gene therapy development priorities, with an update on the preclinical diabetes program.
Chief medical officer Mark Berger, MD, will attend for investor meetings.
